29 participants
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-08-05
- Start Date:
- 2011-12-12
- Completion:
- 2018-07-30
Conditions
- Pancreatic Alpha Cell Carcinoma
- Pancreatic Beta Islet Cell Carcinoma
- Pancreatic Delta Cell Carcinoma
- Pancreatic G-cell Carcinoma
- Recurrent Islet Cell Carcinoma
Interventions
- DRUG